eribulin mesylate

Generic: eribulin mesylate

Labeler: baxter healthcare company
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name eribulin mesylate
Generic Name eribulin mesylate
Labeler baxter healthcare company
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

eribulin mesylate .5 mg/mL

Manufacturer
Baxter Healthcare Company

Identifiers & Regulatory

Product NDC 10019-080
Product ID 10019-080_d075592c-a613-41ff-975a-e0855110fb75
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217250
Listing Expiration 2027-12-31
Marketing Start 2024-10-01

Pharmacologic Class

Classes
microtubule inhibition [pe] microtubule inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 10019080
Hyphenated Format 10019-080

Supplemental Identifiers

RxCUI
1045456
UPC
0310019080017
UNII
AV9U0660CW

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name eribulin mesylate (source: ndc)
Generic Name eribulin mesylate (source: ndc)
Application Number ANDA217250 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • .5 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01) / 2 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

Ingredients (1)

eribulin mesylate (.5 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "d075592c-a613-41ff-975a-e0855110fb75", "openfda": {"upc": ["0310019080017"], "unii": ["AV9U0660CW"], "rxcui": ["1045456"], "spl_set_id": ["62690292-b1de-46f1-b6e8-012a725f8c63"], "manufacturer_name": ["Baxter Healthcare Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "10019-080-01", "marketing_start_date": "20241201"}], "brand_name": "Eribulin Mesylate", "product_id": "10019-080_d075592c-a613-41ff-975a-e0855110fb75", "dosage_form": "INJECTION", "pharm_class": ["Microtubule Inhibition [PE]", "Microtubule Inhibitor [EPC]"], "product_ndc": "10019-080", "generic_name": "Eribulin Mesylate", "labeler_name": "Baxter Healthcare Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Eribulin Mesylate", "active_ingredients": [{"name": "ERIBULIN MESYLATE", "strength": ".5 mg/mL"}], "application_number": "ANDA217250", "marketing_category": "ANDA", "marketing_start_date": "20241001", "listing_expiration_date": "20271231"}